Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women
Clinical trial NCT01300351 · COMPLETED
Trial details
- NCT number
- NCT01300351
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-03-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.